Allergan shareholders can take Valeant's offer

Valeant Pharmaceuticals (VRX) begins an exchange offer whereby Allergan (AGN +0.8%) shareholders can trade each of their shares for $72 in cash plus 0.83 shares of VRX stock or an amount of cash or a number of VRX shares, subject to proration. The all-stock and all-cash alternatives will have the same value as the cash-and-stock offer. Their specific values will be determined prior to the August 15 expiration date (unless extended).

From other sites
Comments (1)
  • Malayan
    , contributor
    Comment (1) | Send Message
    Valient is a house of cards that sounds likel a Ponzi scheme Nick Mjolsness
    20 Jun 2014, 03:46 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs